- Home
- BTDR vs KNSA Comparison
BTDR vs KNSA Comparison
Compare BTDR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTDR
- KNSA
- Stock Information
- Founded
- BTDR 2021
- KNSA 2015
- Country
- BTDR Singapore
- KNSA United Kingdom
- Employees
- BTDR N/A
- KNSA N/A
- Industry
- BTDR EDP Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- BTDR Technology
- KNSA Health Care
- Exchange
- BTDR Nasdaq
- KNSA Nasdaq
- Market Cap
- BTDR 2.6B
- KNSA 2.6B
- IPO Year
- BTDR N/A
- KNSA 2018
- Fundamental
- Price
- BTDR $13.64
- KNSA $36.23
- Analyst Decision
- BTDR Strong Buy
- KNSA Strong Buy
- Analyst Count
- BTDR 9
- KNSA 6
- Target Price
- BTDR $20.61
- KNSA $40.83
- AVG Volume (30 Days)
- BTDR 3.9M
- KNSA 427.3K
- Earning Date
- BTDR 08-18-2025
- KNSA 10-28-2025
- Dividend Yield
- BTDR N/A
- KNSA N/A
- EPS Growth
- BTDR N/A
- KNSA N/A
- EPS
- BTDR N/A
- KNSA 0.07
- Revenue
- BTDR $356,757,000.00
- KNSA $529,332,000.00
- Revenue This Year
- BTDR $64.87
- KNSA $37.21
- Revenue Next Year
- BTDR $89.53
- KNSA $11.99
- P/E Ratio
- BTDR N/A
- KNSA $561.45
- Revenue Growth
- BTDR N/A
- KNSA 56.18
- 52 Week Low
- BTDR $5.62
- KNSA $17.82
- 52 Week High
- BTDR $26.99
- KNSA $37.25
- Technical
- Relative Strength Index (RSI)
- BTDR 52.78
- KNSA 69.86
- Support Level
- BTDR $11.85
- KNSA $33.25
- Resistance Level
- BTDR $14.71
- KNSA $34.16
- Average True Range (ATR)
- BTDR 0.99
- KNSA 0.93
- MACD
- BTDR 0.00
- KNSA 0.14
- Stochastic Oscillator
- BTDR 62.59
- KNSA 76.61
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.